314 related articles for article (PubMed ID: 21172030)
21. Dyslipidemia in type 2 diabetes mellitus.
Gadi R; Samaha FF
Curr Diab Rep; 2007 Jun; 7(3):228-34. PubMed ID: 17547840
[TBL] [Abstract][Full Text] [Related]
22. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
23. The importance of dyslipidaemia in the pathogenesis of cardiovascular disease in people with diabetes.
Gonna H; Ray KK
Diabetes Obes Metab; 2019 Apr; 21 Suppl 1():6-16. PubMed ID: 31002453
[TBL] [Abstract][Full Text] [Related]
24. The role of fibrate treatment in dyslipidemia: an overview.
Katsiki N; Nikolic D; Montalto G; Banach M; Mikhailidis DP; Rizzo M
Curr Pharm Des; 2013; 19(17):3124-31. PubMed ID: 23317397
[TBL] [Abstract][Full Text] [Related]
25. A new perspective in the treatment of dyslipidemia : can fenofibrate offer unique benefits in the treatment of type 2 diabetes mellitus?
Steiner G
Treat Endocrinol; 2005; 4(5):311-7. PubMed ID: 16185099
[TBL] [Abstract][Full Text] [Related]
26. Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitus.
Betteridge J
Am J Med; 2005 Dec; 118 Suppl 12A():10-5. PubMed ID: 16356802
[TBL] [Abstract][Full Text] [Related]
27. Effect of Switching From Statin Monotherapy to Ezetimibe/Simvastatin Combination Therapy Compared With Other Intensified Lipid-Lowering Strategies on Lipoprotein Subclasses in Diabetic Patients With Symptomatic Cardiovascular Disease.
Le NA; Tomassini JE; Tershakovec AM; Neff DR; Wilson PW
J Am Heart Assoc; 2015 Oct; 4(10):e001675. PubMed ID: 26486166
[TBL] [Abstract][Full Text] [Related]
28. The role of lipid-lowering therapy in preventing coronary heart disease in patients with type 2 diabetes.
Karalis DG
Clin Cardiol; 2008 Jun; 31(6):241-8. PubMed ID: 17847038
[TBL] [Abstract][Full Text] [Related]
29. Statins and diabetes.
Carmena R; Betteridge DJ
Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
[TBL] [Abstract][Full Text] [Related]
30. Treatment of diabetic dyslipidemia.
Garg A
Am J Cardiol; 1998 Feb; 81(4A):47B-51B. PubMed ID: 9526814
[TBL] [Abstract][Full Text] [Related]
31. Treating Dyslipidemia in Type 2 Diabetes.
Nelson AJ; Nicholls SJ
Cardiol Clin; 2018 May; 36(2):233-239. PubMed ID: 29609753
[TBL] [Abstract][Full Text] [Related]
32. Management of dyslipidemia in diabetes.
Solano MP; Goldberg RB
Cardiol Rev; 2006; 14(3):125-35. PubMed ID: 16628021
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular disease risk of type 2 diabetes mellitus and metabolic syndrome: focus on aggressive management of dyslipidemia.
Falko JM; Moser RJ; Meis SB; Caulin-Glaser T
Curr Diabetes Rev; 2005 May; 1(2):127-35. PubMed ID: 18220588
[TBL] [Abstract][Full Text] [Related]
34. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
35. The therapeutic role of niacin in dyslipidemia management.
Boden WE; Sidhu MS; Toth PP
J Cardiovasc Pharmacol Ther; 2014 Mar; 19(2):141-58. PubMed ID: 24363242
[TBL] [Abstract][Full Text] [Related]
36. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
Oki JC
Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
[TBL] [Abstract][Full Text] [Related]
37. Diabetic dyslipidemia: extending the target beyond LDL cholesterol.
Nicholls SJ; Lundman P; Tardif JC
Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S20-4. PubMed ID: 20489416
[TBL] [Abstract][Full Text] [Related]
38. Contribution of ApoCIII to Diabetic Dyslipidemia and Treatment With Volanesorsen.
Zhang J; Rocha NA; McCullough PA
Rev Cardiovasc Med; 2018 Mar; 19(1):13-19. PubMed ID: 31032598
[TBL] [Abstract][Full Text] [Related]
39. Drug treatment of hyperlipidaemia: a guide to the rational use of lipid-lowering drugs.
Toth PP
Drugs; 2010 Jul; 70(11):1363-79. PubMed ID: 20614945
[TBL] [Abstract][Full Text] [Related]
40. Practical management of dyslipidemia with elevated lipoprotein(a).
Riche DM; East HE; Priest HM
J Am Pharm Assoc (2003); 2008; 48(6):803-7. PubMed ID: 19019811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
